e-ISSN: Pending
Negative / Null Result ReportOpen accessImmunology and Microbiology· cited by 27

Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells

Makoto Miyara; Driss Chader; Aude Burlion; Jérémie D. Goldstein; Delphine Sterlin; Françoise Norol; Hélène Trebeden‐Negre; Laetitia Claër · 2016 · Oncotarget

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

// Makoto Miyara 1,2 , Driss Chader 1,2 , Aude Burlion 2 , Jérémie Goldstein 2 , Delphine Sterlin 1,2 , Françoise Norol 3 , Hélène Trebeden-Nègre 3 , Laetitia Claër 1,2 , Shimon Sakaguchi 4,* , Gilles Marodon 2,* , Zahir Amoura 1,2,5,6,* and Guy Gorochov 1,2,6 1 Department of immunology, AP-HP Pitié Salpêtrière, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France 3 Cell Therapy, AP-HP Pitié Salpêtri&egrave

Abstract by Makoto Miyara; Driss Chader; Aude Burlion; Jérémie D. Goldstein; Delphine Sterlin; Françoise Norol; Hélène Trebeden‐Negre; Laetitia Claër, Oncotarget (2016) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.18632/oncotarget.10914